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ABSTRACT
The senescence of human mesenchymal stem cells
(hMSCs) causes disruption of tissue and organ mainte-
nance, and is thus an obstacle to stem cell-based therapies
for disease. Although some researchers have studied
changes in the characteristics of hMSCs (decreases in dif-
ferentiation ability and self-renewal), comparing young
and old ages, the mechanisms of stem cell senescence have
not yet been deﬁned. In this study, we developed a growth
curve for human bone marrow derived MSCs (hBMSCs)
which changes into a hyperbolic state after passage num-
ber 7. Senescence associated b-galactosidase (SA b-gal)
staining of hBMSCs showed 10% in passage 9 and 45% in
passage 11. We detected an increase in endogenous super-
oxide levels during senescence that correlated with senes-
cence markers (SA b-gal, hyperbolic growth curve).
Interestingly, even though endogenous superoxide
increased in a replicative senescence model, the expression
of APE1/Ref-1, which is sensitive to intracellular redox
state, decreased. These effects were conﬁrmed in a stress-
induced senescence model by exogenous treatment with
H2O2. This change is related to the p53 activity that nega-
tively regulates APE1/Ref-1. p21 expression levels, which
represent p53 activity, were transiently increased in pas-
sage 9, meaning that they correlated with the expression
of APE1/Ref-1. Overexpression of APE1/Ref-1 suppressed
superoxide production and decreased SA b-gal in
hBMSCs. In conclusion, intracellular superoxide accumu-
lation appears to be the main cause of the senescence of
hBMSCs, and overexpression of APE1/Ref-1 can rescue
cells from the senescence phenotype. Maintaining charac-
teristics of hBMSCs by regulating intracellular reactive
oxygen species production can contribute to tissue regen-
eration and to improved cell therapy. STEM CELLS
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INTRODUCTION
Mesenchymal stem cells (MSCs) maintain the ability to repli-
cate due to their long-term self-renewal potential and their
ability to differentiate into multiple lineages are a renewable
source of replacement cells and tissues to treat myriad dis-
eases and disabilities, including heart disease, osteoarthritis,
rheumatoid arthritis, and tendon rupture [1]. However, MSCs
undergo an alteration in their physiological properties during
in vitro culture and the mechanisms underlying this transition
remain elusive.
Senescence has been reported to occur during in vitro
expansion of stem cell populations, but the underlying mecha-
nism is not clear. The signs of senescence include a diminish-
ing ability to undergo cell division, an increase in cell size,
increased actin stress ﬁber, and increased b-galactosidase ac-
tivity in vitro [2]. Isolated MSCs from older donors have a
similar phenotype to in vitro senescent cells. The ability to
proliferate is decreased, cell size is enlarged, there are
increases in the levels of biomarkers of aging and increases in
levels of reactive oxygen species (ROSs) in older age groups
compared with younger age groups [3].
ROSs have roles as mediators of growth signaling for
induction of cell proliferation, in responses to stress, and in
energy metabolism [4, 5]. In the case of MSCs, ROSs are
also involved in signaling, proliferation, and differentiation
[6, 7]. However, if ROS accumulate in the cell due to
extended oxidative stress or irreparable DNA damage, they
can lead to apoptotic cell death or to senescence through the
p53 pathway [8, 9]. The p53 tumor suppressor gene is
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involved in cell cycle regulation, apoptosis, senescence, and
differentiation in several biological systems. Some researchers
have suggested that p53 has a role in aging because p53 indu-
ces expression of p16 in senescent cells. But others consider
p53 to be a sensor for ROS thus having a role in antiageing
[10–12]. Because of inducing the expression of antioxidant
genes (sestrin, gpx1, adh1), a basal level of p53 can be a pri-
mary barrier to DNA damage [13]. Numerous articles have
reported that p21 has a role in maintaining long-term self-
renewal of stem cells, and prevent stem cell exhaustion and
cell cycle arrest [11, 14].
To prevent ROS accumulation, cells have several antioxi-
dant systems including enzymes such as superoxide dismu-
tase, catalase, and glutathione peroxidase which transform
ROS to H2O2. Besides antioxidant enzymes, redox-sensitive
molecules (Trx, APE1/Ref-1) protect the cell from oxidative
stress [15]. The apurinic/apyrimidinic endonuclease1/redox fac-
tor-1 (APE1/Ref-1) decreases intracellular ROS by inhibiting
rac1 regulated NAD(P)H oxidase [16]. Activation of APE1/
Ref-1 increases the binding of oxidative stress regulating tran-
scription factors (Hif-1, p53, Ap-1). In aged rats, APE1/Ref-1
is decreased and responses to stress in the brain are defective
[17, 18]. Hence, we can postulate that APE1/Ref-1 regulates
the proliferation of MSCs by preventing ROS accumulation.
There are many studies on the relationship between p53 and
APE1/Ref-1 [19, 20]. Oxidized APE1/Ref-1 facilitates p53
DNA binding. In contrast, p53 is a negative regulator of APE1/
Ref-1 interfering sp1 binding to the APE1/Ref-1 promoter.
Herein we present the relationship between the oxidative
stress of human bone marrow derived MSCs (hBMSCs) aging
and APE1/Ref-1. In addition, we examined p53 activity dur-
ing senescence of hBMSCs. We predicted APE1/Ref-1 would
have an antisenescence effect via effects on fundamental cel-
lular antioxidant system.
MATERIALS AND METHODS
Isolation and Culture of hBMSCs
Bone marrow (BM) samples were obtained with informed con-
sent (according to the ethical standard of the local ethical com-
mittee and with the Declarations of Helsinki in 1995) from three
healthy donors undergoing BM harvest. hBMSCs were isolated as
previously described [21]. Brieﬂy, mononuclear cell (MNC) frac-
tion was isolated by Percoll density gradient centrifugation. MNC
was seeded at an Iscove’s modiﬁed Dulbecco’s medium (IMDM)
with 20% heat inactivated fetal bovine serum, 2 mM L-glutamine,
penicillin (100 units/ml), and streptomycin (100 lg/ml). After 7–
10 days, trypsinized and replated in a new culture ﬂask. The cells
(passage number 1) were incubated at 37C under air with 5%
CO2. The medium was replaced every 3–4 days. At 80% conﬂu-
ence, cells were removed with 0.025% Trypsin-EDTA and placed
in fresh culture plates. We conﬁrmed the characterization of our
cells using a mesenchymal stem cell kit (Chemicon, Temecula,
CA, http://www.chemicon.com). The potential for differentiation
into mesodermal lineages was conﬁrmed by a previously
described method [22]. These results strongly suggest that MSCs
used in this experiment have natural character of human mesen-
chymal stem cell that is consistent with other reported hBMSCs
by adding to the supporting information Figure 1.
Measurement of the Time Required
for Population Doublings
Cells (4  104 cells per six-well culture plate) were cultured
at 37C under 5% CO2 in a humidiﬁed incubator. When sub-
cultures reached at 80–90% conﬂuence, cells underwent tryp-
sinization. Population doublings (PDs) were calculated by the
following formula:
PD ¼ lnðNf=NiÞ= lnð2Þ
DT ¼ CT=PD
where DT is the cell-doubling time, CT is the cell culture
time, and PD is the cell-doubling number, Nf is the ﬁnal num-
ber of cells, and Ni is the initial number of cells.
Immunocytochemistry
The hBMSCs in each phase were grown on 12-well plates for
24 hours. Cells were then ﬁxed with 3% paraformaldehyde
and permeabilized with Triton X-100. After blocking with 1%
BSA, cells were incubated with anti-APE1/Ref-1 antibody
(1:250; Santa Cruz Biotechnology Inc., Santa Cruz, CA,
http://www.scbt.com) and FITC-conjugated anti-mouse sec-
ondary antibody according to the manufacturer’s instructions
(Santa Cruz Biotechnology Inc.). For characterization of
hBMSCs, cells were stained with anti CD54, CD45, CD14,
integrin 1-b, and collagen type 1. Slides were coverslipped
with mounting medium and photos were taken on an Olympus
confocal microscope under 400 magniﬁcation. Mean ﬂuores-
cence intensity (MFI) was determined by TINA 2.0 program
Figure 1. Long-term growth curve of human bone marrow derived
MSCs (hBMSCs) and increases in SA b-galactosidase activity during
in vitro expansion. (A): Indicated p7, p9, and p11 represent early,
middle, and late phases of the human mesenchymal stem cell life
span. Each point represents the mean  SD. (B-a): To identify senes-
cent cells, hBMSCs were stained for SA b-galactosidase for each pas-
sage number. The cells were observed on the indicated day under phase
contrast light microscopy and photography. Scale bar ¼ 50 lM. (B-b):
Ten percent and 45% staining for SA b-gal at each passage number (p9,
p11). p7 did not show staining. Abbreviations: PDs, population dou-
blings; SA b-gal, senescence associated b-galactosidase.
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that can relative quantiﬁcation of ﬂuorescence intensity by nu-
cleus of randomly selected 10 cells.
Analysis of Superoxide Production
Confocal Microscopy. Endogenous superoxide production
was evaluated using the oxidative ﬂuorescent dye DHE (dihy-
droethidium). In each phase of growth of hBMSCs, cells were
grown on 12-well plates for 24 hours and then washed with
Krebs-HEPES buffer (pH 7.4). Cells were stained with DHE
for 15 minutes at 37C in an incubator. After ﬁxation with
paraformaldehyde, slides were coverslipped with mounting
medium and photos were taken on an Olympus confocal
microscope under 400 magniﬁcation.
Flow Cytometry. The quantiﬁcation of endogenous superox-
ide production was done by ﬂow cytometry. Afterward the
cells were stained with DHE as above, the cells were removed
using trypsin and collected in centrifuge tubes. After centrifu-
gation, pellets were resuspended in Krebs-HEPES buffer (pH
7.4). Fluorescence intensity was calculated for 10,000 cells
with Cell Quest software using FACscan (Becton, Dickinson
and Company, Franklin Lakes, NJ, http://www.bd.com).
Senescence-Associated b-Galactosidase Assay
Senescence associated b-galactosidase (SA b-gal) was assayed
at pH 6.0 as described by Yoon et al. with a slight modiﬁca-
tion [23]. Brieﬂy, cells were washed twice with PBS, ﬁxed to
plates using 3% paraformaldehyde for 3 minutes, washed with
PBS, and then incubated overnight in freshly prepared staining
in 1 mg/ml 5-bromo-4-chloroindol-3-yl b-D-galactopyranoside
(Amersham Biosciences, Piscataway, NJ, http://www.amer-
sham.com, Cat. US10077), 5 mM potassium ferrocyanide, 150
mM NaCl, and 2 mM MgCl2. The stain was visible at 24 hours
after incubation at 37C. The percentage of senescence-associ-
ated cells was obtained by counting the number of blue-stained
cells and the total cells per ﬁeld (0.5  0.5 cm2) under an
inverted microscope. More than 500 cells were counted from
ﬁve ﬁelds and are presented as mean  SD.
MTT Cell Viability Assay
Viable adherent cells were stained with MTT (3-(4,5-dime-
thylthiazol-2-yl)-2,3-diphenyl-tetrazolium bromide) (2 mg/ml)
for 2 hours. Media were then removed and the formazan crys-
tals produced were dissolved by adding 100 ll of dimethyl-
sulfoxide. Absorbance was assayed at 570 nm and cell viabil-
ity is expressed as a ratio versus untreated control cells.
Preparation of Cell Lysates and
Western Blot Analysis
Proteins were extracted with radioimmunoprecipitation
(RIPA) buffer (10 mM TrisHCl, pH 8.0; 150 mM NaCl; 1%
Nonidet P-40) containing protease inhibitors (Roche, Mann-
heim, Germany, http://www.roche.de). Protein concentrations
were measured using the Bradford method [24]. Samples
were resolved through a 10% SDS-polyacrylamide gel and
transferred to Hybond ECL membranes (Amersham Pharma-
cia Biotech, Buckinghamshire, U.K.). The membrane was
blocked in Tris-buffered saline containing 0.1% Tween 20
with 5% nonfat skim milk for 1 hour at room temperature
and incubated with primary antibody for 1 hour at room tem-
perature. After three washes in tris-buffered saline containing
0.1% Tween 20 (TBS/T), the membrane was incubated with
horseradish peroxidase-conjugated secondary antibody for
1-hour at reverse transcriptase (RT). After three washes in
TBS/T, the membrane was visualized by enhanced chemilu-
minescence (Amersham Pharmacia Biotech, Buckinghamshire,
U.K.).
RNA Isolation and Reverse Transcriptase
Polymerase Chain Reaction
Total RNA was isolated using TRIzol reagent (Invitrogen,
Carlsbad, CA, http://www.invitrogen.com) according to the
manufacturer’s instructions. Single-stranded cDNA was syn-
thesized in a 20 ll ﬁnal volume containing 2 lg of total
RNA, 4 ll of 5 Reverse Transcriptase buffer, 4 ll of 2.5
mM dNTP, 1 ll of oligo-dT (100 pmol/ll), 1 ll of RNase in-
hibitor (4 units/ll), and 1 ll AMV reverse transcriptase (5
units/ll) at 42C for 1 hour. Afterward the reaction the mix-
ture was boiled for 5 minutes to inactivate RT and quickly
chilled on ice. The gene-speciﬁc primers used for PCR ampli-
ﬁcation were: APE1/Ref-1 (Forward: 50-CGGAATTCCAT
GCCGAAGCGTGGGAAAAAGGGAG-30, Reverse: 50-CGC
AAGCTTTCACAGTGCTAGGTATAGGGTG-30) Glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) (Forward: 50-AAG
GTCGGAGTCAACGGATT-30, Reverse: 50-CTC CTGGAAGAT
GGTGATGG-30). Ten nanograms of total single-strand cDNA
reaction were used as a template. Ampliﬁcations were per-
formed in a total volume of 20 ll containing 4 ll of 5 PCR
premixture (Elpis Biotech, Daejeon, Korea, http://www.
elpisbio.com), in each 1 ll of primer pair (10 pmol/ll). After
an initial incubation at 94C for 5 min, the ampliﬁcation pro-
ﬁle included denaturation at 94C for 45 seconds, primer
annealing at 58C for 45 minutes, and extension at 72C for
1 minute. PCR products were analyzed by 1.5% agarose gel-
electrophoresis. PCR was performed using a thermal cycler
(Mastercycler gradient, Eppendorf, Westbury, NY, http://
www.eppendorf.com).
Adenoviral Transfections
An adenovirus encoding green ﬂuorescent protein (AdGFP)
and human full length APE1/Ref-1 (AdRef-1) were generated
by homologous recombination in HEK 293 cells as previously
described [25, 26]. Then, virus-containing media were puriﬁed
using the Adeno-X virus puriﬁcation kit purchased from Clon-
tech (Mountain View, CA), according to the manufacturer’s
instructions. MSCs were infected with the 50 multiplicity of
infection (MOI; particle forming units per cell) of adenovirus
for 48 hours. We choose the AdGFP as control virus and had
consistent results with Clements et al. in transfection efﬁ-
ciency and long-term assessment for hBMSCs [27].
Statistical Analysis
Statistical analyses were done as recommended by an inde-
pendent analyst. These included the unpaired Student’s t test.
All values are expressed as mean  SD, and statistical signiﬁ-
cance was accepted for p values of <.05.
RESULTS
Determination of the Senescence Phase of
hBMSCs: Early, Middle, and Late Phases
BM derived human mesenchymal stem cells (hBMSCs) are
somatic cells and achieve a maximum of 30–40 PDs in vitro
[28, 29]. During in vitro expansion, broad, enlarged, and ﬂat-
tened morphologic changes were seen from around passage
number 9 and progress according to culture time. hBMSCs
reached a stationary phase at 35–41 PDs which corresponds
to passage number 12 and 13 (Fig. 1A). The results are repre-
sentative three experiments. The growth curve for hBMSCs
suggests that hBMSCs, even if they are stem cells, can be
senescent. The Stenderup group divided the life of hBMSCs
into three phases according to the time of the life span [2].
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We found that the early linear growth curve changed to a
hyperbolic curve. To investigate the continuous changes in
hBMSCs during senescence, we divided the total life span of
hBMSCs into three phases depending on their replication abil-
ity. The ﬁrst is an early phase, before the abrupt increase of
one passage time (25 PDs, passage number 7 [p7], 60% of
total life span). The second is a middle phase from 26 to 32
PDs (passage numbers 8–10 [p8–10], 60–80% of total life
span). The third is a late phase after 32 PDs (passage number
11 [p11], more than 80% of the total life span). For further
experiments, we selected p7, p9, and p11 as representatives of
early, middle, and late phases, respectively.
To characterize in vitro senescence, hBMSCs were moni-
tored using the SA b-gal assay. Consistent with the growth
proﬁle (Fig. 1A), the percent of SA b-gal positive cells was
0% in p7, about 10% in p9, and about 45% in p11 (Fig. 1B-a,
1B-b). Results represent the mean  SD of three independent
experiments (p < .01).
Superoxide Production by hBMSCs
During In Vitro Expansion
Recently, it was reported that levels of reactive oxygen spe-
cies are higher in MSCs obtained from older than younger
individuals. However, it is not known whether ROS are
involved in the senescence of hMSCs during in vitro expan-
sion. Therefore, we measured superoxide production during in
vitro expansion of hBMSCs using DHE (dihydroethidium)
staining as described in Materials and Methods section.
As shown in Figure 2A, punctuated red ﬂuorescence was
more intense in p11 hBMSCs than p7 hBMSCs, suggesting
that superoxide production is closely related with in vitro
Figure 2. Endogenous superoxide increased during mesenchymal
stem cell replicative senescence measured by dihydroethidium (DHE)
staining and conﬁrmed by FACS analysis. (A): Endogenous superoxide
was observed by DHE staining (red) following on confocal microscopy.
Scale bar¼ 20 lM. (B-a): Quantiﬁcation of endogenous superoxide lev-
els was done by DHE staining followed by ﬂuorescence-activated cell
sorting analysis. (B-b):Mean ﬂuorescence intensity was measured along
with increases in passage number by ﬂuorescence-activated cell sorting.
Each point represents the mean SD.
Figure 3. Redox factor-1 decreases its intracellular level by immunoﬂuorescence, mRNA, and protein change in replicative senescence. (A): In-
tracellular redox factor-1 was observed by confocal microscopy in each cellular phase. Scale bar ¼ 20 lM. Mean ﬂuorescence intensity was
measured in the nucleus of 10 randomly selected cells. (B): Total RNA was isolated from human bone marrow derived MSCs (hBMSCs). For
each passage number, the mRNA level was measured by semiquantitative reverse transcriptase polymerase chain reaction. (B, C): Each phase of
hBMSCs, RT-PCR, and western blotting detected mRNA and protein levels. Each protein or mRNA expression level was quantiﬁed by densitom-
etry. Error bars represent the mean  SD. Signiﬁcant difference compared with p7. *p < .05; **p < .01. Abbreviations: GAPDH, glyceraldehyde
3-phosphate dehydrogenase; RT-PCR, reverse transcriptase polymerase chain reaction.
1458 APE1/Ref-1 in BMSC Senescence
senescence of hBMSCs. To quantify intracellular superoxide
production, DHE stained cells were analyzed by ﬂow cytome-
try. The p11 hBMSCs showed a right shift compared with p7
hBMSCs (Fig. 2B). In addition, the MFI of p11 hBMSCs
increased threefold over p7 hBMSCs that exhibited signiﬁ-
cantly greater level (p < .01; Fig. 2C).
The Expression of APE1/Ref-1 in Each
Phase of the Senescence of hBMSCs
Increases in intracellular ROS level induce APE1/Ref-1
expression in a hypoxia/reoxygenation system in endothelial
cells or during acute oxidative stress in ﬁbroblasts [16, 30].
As superoxide production increases during the senescence of
hBMSCs, we investigated changes in APE1/Ref-1 expression
or localization in each phase. In immunoﬂuorescent images,
APE1/Ref-1 protein is mainly localized in the nucleus in all
phases (Fig. 3A). During the senescence of hBMSCs, intracel-
lular localization of APE1/Ref-1 did not change. However,
the ﬂuorescent intensity of APE1/Ref-1 decreased with senes-
cence. Quantitative analysis was performed by measuring the
ﬂuorescence intensity in nucleus that is uniformly expressed
to ﬂuorescence. MFI decreased about threefold in p11 over
p7. Results represent the mean  SD of three independent
experiments (p < .01).
To evaluate changes in APE1/Ref-1 protein expression
with senescence, western blots for APE1/Ref-1 were done
using cell homogenates; cells were lysed with RIPA buffer.
APE1/Ref-1 protein expression decreased in p9 and p11 com-
pared with p7. The results of western blots were quantiﬁed
using densitometry. GAPDH was used as a control. APE1/
Ref-1 was decreased 20% at p9 and 70% at p11 (Fig. 3B-b)
which was statistically signiﬁcance of three independent
experiments. APE1/Ref-1 mRNA levels also decreased, which
means that it was downregulated at the transcriptional level
(Fig. 3C).
Effect of Exogenous ROS on APE1/Ref-1
Expression in hBMSCs
Besides replicative senescence, there is another model of in
vitro senescence – stress-induced senescence [31, 32]. We
turned to a hydrogen peroxide induced senescence model to
further study hBMSCs senescence. It has not yet been estab-
lished which concentration of hydrogen peroxide is required
to cause growth arrest of hBMSCs. Hence, we examined cell
viability with regard to dose and time. A dose of 1 mM
hydrogen peroxide had a cytotoxicity such that only 50% of
cells were viable after 2 hours. However, a dose of 800 lM
hydrogen peroxide had no cytotoxic effect and the percent of
viable cells at baseline levels during the entire 48 hours (Fig.
4A). Results represent the mean  SD of three independent
experiments (p < .01).
The APE1/Ref-1 expression level was identiﬁed in the
H2O2 induced senescence model. APE1/Ref-1 expression also
decreased at mRNA and protein levels after treatment with
H2O2 for 48 hours (Fig. 4B, 4C). Therefore, we concluded
that APE1/Ref-1 expression decreases at the transcription
level during in vitro senescence by replication and by oxida-
tive stress.
Change in p21 Expression Level During
the Senescence of hBMSCs
p53 can determine cell fate during oxidative stress [13, 33,
34]. If cells are under mild oxidative stress, p53 induces
genes for cell cycle arrest and DNA repair. Under extended
stress or where there is irreparable DNA damage, p53 induces
prooxidant genes to eliminate mutant cells, to maintain cell
cycle arrest, and to enter senescence [13]. During replicative
senescence, p21 represents one of the downstream elements in
the p53 signaling pathway. We thought that p53 and p21
could also regulate APE1/Ref-1 at the transcriptional level
during senescence. In western blot analysis, the p53 protein
level was slightly decreased at p11. p21 protein was transi-
ently increased at p9. At p11, p21 decreased to less than basal
levels (Fig. 5). Therefore, p21 may have an effect on APE1/
Ref-1 regulation in the middle phase of in vitro expansion. A
reduction in basal p21 expression levels occurs in hBMSCs
during the senescent phase by these cells losing their ability
to maintain quiescence [11]. Results represent the mean  SD
of three independent experiments (p < .01).
Overexpression of APE1/Ref-1 Decreases
Superoxide Generation and Attenuates Senescence
Chronic treatment of N-acetyl cysteine or supplementation
with selenium can reduce senescence markers through reduc-
tion of ROS levels [35, 36]. APE1/Ref-1 can also decrease in-
tracellular ROS levels [16]. But these effects have not been
reported during senescence.
Compared with mock virus, 50 MOI of Adref-1 overex-
pression was increased the APE1/Ref-1 expression level to
1.7-fold that was statistically signiﬁcance in independent three
Figure 4. Dose-dependent effects of exogenous oxidative stress and
decreases in Redox factor-1 mRNA and protein expression during
stress induced senescence of human bone marrow derived MSCs
(hBMSCs). (A): Cell viability after hydrogen peroxide treatment ana-
lyzed by MTT assays. (B): Semiquantitiative RT-PCR of hBMSCs
treated with 200 lM, 400 lM, or 800 lM H2O2 for 2 hours and after
48 hours, applied to APE1/Ref-1 and GAPDH primers. (C): Cells
were treated with 200, 400, or 800 lM H2O2 for 2 hours and after 48
hours, applied to western blotting for APE1/Ref-1 and GAPDH anti-
bodies. Abbreviations: GAPDH, glyceraldehyde 3-phosphate dehydro-
genase; RT-PCR, reverse transcriptase polymerase chain reaction.
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experiments (Fig. 6A). To investigate the effect of APE1/Ref-
1 overexpression in senescence, superoxide levels were quan-
titatively analyzed by ﬂuorescence imaging and FACS with
DHE staining of individual of hBMSCs in each phase. In
comparison with uninfected cells or mock virus infected cells,
cells infected with AdRef-1 showed signiﬁcant suppression of
intracellular superoxide levels (Fig. 6B-a, 6B-b).
Although the mechanism is not fully understood, generally
the SA b-gal assay is believed to be a marker of senescence
[37]. The proportion of SA b-gal positive cells was decreased
to 50% at p9 and p11 by AdRef-1. Therefore, we conclude
that APE1/Ref-1 overexpression attenuates senescence.
Results represent the mean  SD of three independent experi-
ments (p < .01).
DISCUSSION
There are many factors that can cause aging or senescence. Ir-
reversible DNA damage, ROS, and shortening of telomeres
are involved. However, we would like to know what the most
important cause is and what the initiator of aging is. The
ROS theory of aging was among the ﬁrst [38]. If intracellular
ROS levels are not controlled, the increased ROS can cause
DNA damage and result in telomere shortening. In this study,
we found that hBMSCs senescence is related with APE1/Ref-
1, which maintains the intracellular ROS balance.
Differing from embryonic stem cells, adult MSCs undergo
senescence. Because MSCs have a role in maintaining tissues
and organs, the senescence of MSCs can disrupt the integrity
of tissues and organs. Also, recently, MSCs were introduced
as cell therapy in irreversible spinal cord injury, and in tendon
and ligament regeneration. Therefore, maintenance of natural
MSCs characteristics is very important. We conﬁrmed that
MSCs in our culture system undergo senescence during in
vitro expansion according to a hyperbolic growth curve, and
show increased SA b-gal activity and increased stress ﬁbers,
these are known as markers of senescence.
The overall balance between oxidants and antioxidants
maintains the function of the organ and/or tissue, preventing
disease outcome. APE1/Ref-1, one of the Redox modulating
genes, expression level decreased during in vitro expansion of
hBMSCs despite intracellular ROS level increased. This
reduction in APE1/Ref-1 was conﬁrmed in the stress-induced
senescence model. These results correlated with the in vivo
experiment that APE1/Ref-1 expression reduced in the hippo-
campus of aged rats [18]. But in case of mild oxidative stress
through the low-dose treatment with H2O2, APE1/Ref-1 has
been shown to activate [30]. The different expressions of
APE1/Ref-1 in each model are seemed to be a result from the
degree of strength and the duration of stress to the cell.
There are limited reports on in vitro replicative senes-
cence mechanism of hBMSCs. The glutathione peroxidase
deﬁciency can cause senescence of hBMSCs. It supports the
ROS theory of senescence of stem cells [36]. In view of the
regulation of oxidative stress by APE1/Ref-1, accelerated se-
nescence could be a result from transcriptional downregula-
tion because the proliferation ability is remained and mRNA
level is also decreased. Also, long-term exposure of hBMSCs
to ROS leads to senescence. In the stress-induced senescence
model, exogenous treatment with H2O2 causes growth arrest
and seems to overwhelm intracellular antioxidative capacity.
Extended exposure of hBMSCs to oxidative stress reduces
APE1/Ref-1 expression levels and can augment the effect of
ROS on hBMSCs senescence.
p53 increases its protein level and activity during in vitro
senescence, but recently p53 was found to decrease in the last
phase of aging [39]. Although p21 is known to be induced by
p53, at p7 an increase in p21 was not observed despite a high
p53 level. A p21 increase was detected at p9 after APE1/Ref-
1 and p53 were decreased. According to studies by Alcorta et
al. replicative cellular senescence is a multistep process and
p21 expression precedes p16 expression [30]. So p21 is
Figure 5. Change in p21 expression level
in each phase of senescence of human
bone marrow derived MSCs (hBMSCs).
(A): hBMSCs were sampled at the same
time in each phase of senescence and ana-
lyzed by western blotting using APE1/Ref-
1, p53, p21, and GAPDH antibodies. (B,
C): Protein expression level was analyzed
quantitatively by densitometry. Error bars
represent the mean  SD. Signiﬁcant dif-
ference compared with p7. *p < .05; **p
< .01. Abbreviations: GAPDH, glyceralde-
hyde 3-phosphate dehydrogenase.
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thought to be the initiator of terminal hBMSCs senescence. In
the past, APE1/Ref-1 was found to increase p53 transcrip-
tional binding activity. In more recent ﬁndings, p53 has role
of negatively transcriptional regulation to the APE1/Ref-1 by
binding to the promoter region of APE1/Ref-1. We conclude
that long lasting increases in p53 activity can induce p21
induction and may suppress APE1/Ref-1 function in hBMSCs,
consistent with Zaky’s ﬁndings [20].
Adenoviral induced APE1/Ref-1 expression in hBMSCs
could prevent cellular senescence whereas it reduces SA b-gal
staining and intracellular superoxide levels. Although there is
no single marker of senescence, SA b-gal staining is believed
to be the most reliable marker of senescence. In the SA b-gal
assay, APE1/Ref-1 overexpression seemed to reverse senes-
cence but superoxide reduction was observed only at p7, not
at p9 or p11 (data not shown). But the reason why there was
a difference between phases needs to be further studied.
The ideal protocol for hBMSCs preparation and expansion
to improve cell therapy has not yet been deﬁned. It is obvious
that APE1/Ref-1 is downregulated during senescence, which
means that maintaining a balance between ROS and antioxi-
dants is important in expansion of hBMSCs. In addition, p53
is involved in senescence by regulation of p21 and APE1/
Ref-1. Our ﬁndings on molecular mechanisms of the limita-
tion of cell expansion may contribute to the prevention of
hBMSC senescence and may beneﬁt therapies for otherwise
irreparable disease. However, there are some limitations to
application to the clinical ﬁeld. The ﬁrst, we used adenoviral
overexpression system that has a drawback to be introduced
into human. The second, we only performed in in-vitro sys-
tem. Because of some difference between in vitro and in vivo
study, the in vivo study must be preceded before it does the
application to human. Taken together, clinical application for
cell therapy is carefully recommended until the safety is
uncovered.
CONCLUSION
We show that the self-renewal ability of MSCs depends on
intracellular ROS levels and antioxidative capacity. We
obtained novel ﬁndings about the relationship between APE1/
Ref-1 and MSC senescence. During senescence, extended oxi-
dative stress is a negative transcriptional regulator of APE1/
Ref-1 via the p53 pathway. The reduction in APE1/Ref-1 is
correlated with the senescence growth curve and increases the
speed of development of senescence. By use of an adenoviral
overexpression system, APE1/Ref-1 diminishes senescence
markers and superoxide accumulation. This could enhance
Figure 6. Overexpression of AdRef-1 decreased superoxide accumulation and attenuated SA b-gal. (A): Forty-eight hours after transfection of
AdRef-1, overexpression was conﬁrmed by western blotting. (B-a): Endogenous superoxide levels were detected by DHE staining using confocal
microscopy. (B-b): Quantiﬁcation of endogenous superoxide levels was done by DHE staining following ﬂuorescence-activated cell sorting analy-
sis (FACS). (B-c): Mean ﬂuorescence intensity was measured along with increases in passage number by FACS. Each point represents the mean
 SD. (C-a): Overexpression of AdRef-1 changed SA b-gal staining during senescence. (C-b): Statistical analysis of SA b-gal staining showed a
signiﬁcant decrease during the senescence phase compared to mock virus. Signiﬁcant difference compared with p7. *p < .05; **p < .01. Abbre-
viations: GAPDH, glyceraldehyde 3-phosphate dehydrogenase; SA b-gal, senescence associated b-galactosidase.
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organ and tissue regeneration and can be of beneﬁt in cell
therapies.
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